Laura Scortichini

Macerata, 62100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.

Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.

Journal: Recenti progressi in medicina

Published: September 02, 2026

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.

Journal: Cancers

Published: March 31, 2025

Effects of Eribulin on the RNA Content of Extracellular Vesicles Released by Metastatic Breast Cancer Cells.

Effects of Eribulin on the RNA Content of Extracellular Vesicles Released by Metastatic Breast Cancer Cells.

Journal: Cells

Published: September 22, 2023

Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Journal: Molecular and clinical oncology

Published: April 07, 2022

Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knows.

Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knows.

Journal: Exploration of targeted anti-tumor therapy

Published: December 05, 2021

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience.

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience.

Journal: Cancers

Published: September 28, 2021

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience.

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience.

Journal: Journal of oncology

Published: March 02, 2021

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?

Journal: World journal of clinical oncology

Published: February 27, 2021

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management.

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management.

Journal: Cancer management and research

Published: February 29, 2020

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management.

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management.

Journal: Therapeutics and clinical risk management

Published: January 01, 2020

Systemic treatment for lung carcinoids: from bench to bedside.

Systemic treatment for lung carcinoids: from bench to bedside.

Journal: Clinical and translational medicine

Published: April 14, 2019

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase.

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: December 15, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026